Physician profile
Elisabeth Fox
NPI 1053491704
$1,040.69
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $88.09 · 2021: $91.84 · 2022: $206 · 2023: $358 · 2024: $43.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $301.93 | 2019-2023 | |
| Genzyme Corporation | $118.63 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $112.20 | 2022-2023 | Seglentis |
| Medtronic, INC. | $104.55 | 2023 | Propel |
| Glaxosmithkline, LLC. | $92.51 | 2021-2023 | Nucala |
| Regeneron Healthcare Solutions, INC. | $62.51 | 2023-2024 | Dupixent |
| Smith+Nephew, INC. | $58.17 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $48.95 | 2019 | |
| Stryker Corporation | $48.31 | 2019-2020 | |
| Acclarent, INC | $30.33 | 2022-2024 | Trudi Nav Cable |
| Aerin Medical INC. | $29.18 | 2023 | |
| Merck Sharp & Dohme LLC | $19.40 | 2023 | |
| Checkpoint Surgical, INC | $14.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisabeth Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.